132 related articles for article (PubMed ID: 8407554)
1. Infiltrating lymphocytes and accessory cells in nasopharyngeal carcinoma.
Zong YS; Zhang CQ; Zhang F; Ruan JB; Chen MY; Feng KT; Yu ZF
Jpn J Cancer Res; 1993 Aug; 84(8):900-5. PubMed ID: 8407554
[TBL] [Abstract][Full Text] [Related]
2. Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways.
Zhang YL; Li J; Mo HY; Qiu F; Zheng LM; Qian CN; Zeng YX
Mol Cancer; 2010 Jan; 9():4. PubMed ID: 20064222
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of accessory cells and lymphocytes in nasopharyngeal carcinoma.
Giannini A; Bianchi S; Messerini L; Gallo O; Gallina E; Asprella Libonati G; Olmi P; Zampi G
Pathol Res Pract; 1991 May; 187(4):496-502. PubMed ID: 1876530
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Infiltrating T Cell Receptor-Beta Repertoires are Linked to the Risk of Late Chemoradiation-Induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma.
Wu L; Chung YL
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):165-176. PubMed ID: 30654091
[TBL] [Abstract][Full Text] [Related]
5. CD3+T-lymphocyte infiltration is an independent prognostic factor for advanced nasopharyngeal carcinoma.
Al-Rajhi N; Soudy H; Ahmed SA; Elhassan T; Mohammed SF; Khoja HA; Ghebeh H
BMC Cancer; 2020 Mar; 20(1):240. PubMed ID: 32199452
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of AFAP1-AS1 and PD-1 predicts poor prognosis in nasopharyngeal carcinoma.
Tang Y; He Y; Shi L; Yang L; Wang J; Lian Y; Fan C; Zhang P; Guo C; Zhang S; Gong Z; Li X; Xiong F; Li X; Li Y; Li G; Xiong W; Zeng Z
Oncotarget; 2017 Jun; 8(24):39001-39011. PubMed ID: 28380458
[TBL] [Abstract][Full Text] [Related]
7. [Immunocyte reaction in stage III nasopharyngeal carcinoma in relation to biological findings and prognosis].
He C; Zhuang H; Zhang W
Zhonghua Bing Li Xue Za Zhi; 1999 Apr; 28(2):115-8. PubMed ID: 11869520
[TBL] [Abstract][Full Text] [Related]
8. Expression of Immune Checkpoint Regulators, Cytotoxic T-Lymphocyte Antigen-4, and Programmed Death-Ligand 1 in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma.
Ahmed MM; Gebriel MG; Morad EA; Saber IM; Elwan A; Salah M; Fakhr AE; Shalaby AM; Alabiad MA
Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):401-408. PubMed ID: 33480605
[TBL] [Abstract][Full Text] [Related]
9. Tumor-infiltrating lymphocytes associate with outcome in nonendemic nasopharyngeal carcinoma: a multicenter study.
Almangush A; Ruuskanen M; Hagström J; Hirvikoski P; Tommola S; Kosma VM; Nieminen P; Mäkitie A; Leivo I
Hum Pathol; 2018 Nov; 81():211-219. PubMed ID: 30030117
[TBL] [Abstract][Full Text] [Related]
10. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
Jiang C; Gao H; Zhang L; Li H; Zhang T; Ma J; Liu B
BMC Cancer; 2020 Jul; 20(1):667. PubMed ID: 32680466
[TBL] [Abstract][Full Text] [Related]
11. Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.
Yip WK; Abdullah MA; Yusoff SM; Seow HF
Clin Exp Immunol; 2009 Mar; 155(3):412-22. PubMed ID: 19220831
[TBL] [Abstract][Full Text] [Related]
12. The Infiltration of ICOS
Zhang G; Xu Y; Zhou H
Pathol Oncol Res; 2020 Jan; 26(1):365-370. PubMed ID: 30361907
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis to identify cytokeratin 18 as a novel biomarker of nasopharyngeal carcinoma.
Li XM; Huang WG; Yi H; Cheng AL; Xiao ZQ
J Cancer Res Clin Oncol; 2009 Dec; 135(12):1763-75. PubMed ID: 19529960
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of IRS-1 is associated with lymph node metastasis in nasopharyngeal carcinoma.
Luo J; Wen Q; Li J; Xu L; Chu S; Wang W; Shi L; Xie G; Huang D; Fan S
Int J Clin Exp Pathol; 2014; 7(9):6117-24. PubMed ID: 25337259
[TBL] [Abstract][Full Text] [Related]
15. Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal carcinoma.
Zhao J; Guo C; Xiong F; Yu J; Ge J; Wang H; Liao Q; Zhou Y; Gong Q; Xiang B; Zhou M; Li X; Li G; Xiong W; Fang J; Zeng Z
Cancer Lett; 2020 May; 477():131-143. PubMed ID: 32061950
[TBL] [Abstract][Full Text] [Related]
16. Identification of tumor-infiltrating immune cells and microenvironment-relevant genes in nasopharyngeal carcinoma based on gene expression profiling.
Zou Z; Ha Y; Liu S; Huang B
Life Sci; 2020 Dec; 263():118620. PubMed ID: 33096113
[TBL] [Abstract][Full Text] [Related]
17. High numbers of granzyme B/CD8-positive tumour-infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcome in patients treated with curative intent.
Oudejans JJ; Harijadi H; Kummer JA; Tan IB; Bloemena E; Middeldorp JM; Bladergroen B; Dukers DF; Vos W; Meijer CJ
J Pathol; 2002 Dec; 198(4):468-75. PubMed ID: 12434416
[TBL] [Abstract][Full Text] [Related]
18. Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis.
Wang L; Wu Z; Xie D; Lv S; Xia L; Su Y
Radiat Oncol; 2020 Jul; 15(1):160. PubMed ID: 32615984
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Cervical Nodal Necrosis in Nasopharyngeal Carcinoma: Analysis of 1800 Patients with Positive Cervical Nodal Metastasis at MR Imaging.
Lan M; Huang Y; Chen CY; Han F; Wu SX; Tian L; Zheng L; Lu TX
Radiology; 2015 Aug; 276(2):536-44. PubMed ID: 25759968
[TBL] [Abstract][Full Text] [Related]
20. Cytokine and immunoglobulin production by PWM-stimulated peripheral and tumor-infiltrating lymphocytes of undifferentiated nasopharyngeal carcinoma (NPC) patients.
Fliss-Jaber L; Houissa-Kastally R; Bouzouita K; Khediri N; Khelifa R
BMC Cancer; 2004 Sep; 4():68. PubMed ID: 15450122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
